全文获取类型
收费全文 | 10857篇 |
免费 | 1133篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 324篇 |
妇产科学 | 238篇 |
基础医学 | 1684篇 |
口腔科学 | 166篇 |
临床医学 | 1290篇 |
内科学 | 1940篇 |
皮肤病学 | 155篇 |
神经病学 | 1248篇 |
特种医学 | 425篇 |
外科学 | 1287篇 |
综合类 | 193篇 |
一般理论 | 5篇 |
预防医学 | 1028篇 |
眼科学 | 182篇 |
药学 | 1124篇 |
中国医学 | 10篇 |
肿瘤学 | 582篇 |
出版年
2021年 | 169篇 |
2020年 | 105篇 |
2019年 | 130篇 |
2018年 | 198篇 |
2017年 | 151篇 |
2016年 | 134篇 |
2015年 | 199篇 |
2014年 | 227篇 |
2013年 | 414篇 |
2012年 | 577篇 |
2011年 | 608篇 |
2010年 | 345篇 |
2009年 | 296篇 |
2008年 | 535篇 |
2007年 | 537篇 |
2006年 | 520篇 |
2005年 | 522篇 |
2004年 | 499篇 |
2003年 | 466篇 |
2002年 | 433篇 |
2001年 | 327篇 |
2000年 | 323篇 |
1999年 | 309篇 |
1998年 | 148篇 |
1997年 | 116篇 |
1996年 | 113篇 |
1995年 | 108篇 |
1994年 | 107篇 |
1993年 | 105篇 |
1992年 | 223篇 |
1991年 | 197篇 |
1990年 | 223篇 |
1989年 | 181篇 |
1988年 | 154篇 |
1987年 | 158篇 |
1986年 | 145篇 |
1985年 | 139篇 |
1984年 | 110篇 |
1983年 | 109篇 |
1982年 | 90篇 |
1981年 | 76篇 |
1980年 | 73篇 |
1979年 | 118篇 |
1978年 | 94篇 |
1977年 | 91篇 |
1975年 | 78篇 |
1974年 | 83篇 |
1973年 | 76篇 |
1972年 | 85篇 |
1971年 | 84篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Breanne E. Kunstler Jill L. Cook Joanne L. Kemp Paul D. O’Halloran Caroline F. Finch 《Journal of Science and Medicine in Sport》2019,22(1):2-10
Objectives
To determine: (i) the behaviour change techniques used by a sample of Australian physiotherapists to promote non-treatment physical activity; and (ii) whether those behaviour change techniques are different to the techniques used to encourage adherence to rehabilitation exercises.Design
Cross-sectional survey.Method
An online self-report survey was advertised to private practice and outpatient physiotherapists treating patients with musculoskeletal conditions. The use of 50 behaviour change techniques were measured using five-point Likert-type scale questions.Results
Four-hundred and eighty-six physiotherapists responded to the survey, with 216 surveys fully completed. Most respondents (85.1%) promoted non-treatment physical activity often or all of the time. Respondents frequently used 29 behaviour change techniques to promote non-treatment physical activity or encourage adherence to rehabilitation exercises. A similar number of behaviour change techniques was frequently used to encourage adherence to rehabilitation exercises (n = 28) and promote non-treatment physical activity (n = 26). Half of the behaviour change techniques included in the survey were frequently used for both promoting non-treatment physical activity and encouraging adherence to rehabilitation exercises (n = 25). Graded tasks was the most, and punishment was the least, frequently reported technique used to promote non-treatment physical activity and encourage adherence to rehabilitation exercises.Conclusions
Respondents reported using similar behaviour change techniques to promote non-treatment physical activity and encourage adherence to rehabilitation exercises. The variability in behaviour change technique use suggests the behaviour the physiotherapist is promoting influences their behaviour change technique choice. Including the frequently-used behaviour change techniques in non-treatment physical activity promotion interventions might improve their efficacy. 相似文献2.
3.
4.
5.
6.
7.
8.
Owen Ngalamika Gongping Liang Ming Zhao Xinhai Yu Yang Yang Heng Yin 《Immunological investigations》2015,44(2):126-136
Immune dysregulation is a cardinal feature of autoimmune diseases and chronic microbial infections. In particular, regulatory T cells are downregulated in autoimmune diseases while upregulated in chronic microbial infections. FOXP3 is the master regulator of Treg development. Treg-specific demethylated region (TSDR) is a highly conserved locus on the FOXP3 gene that is fully demethylated in natural Tregs but methylated in effector T cells. In our study, we used high resolution melt-polymerase chain reaction (HRM-PCR) to determine the FOXP3 TSDR methylation status in autoimmune diseases and chronic microbial infections. We found that FOXP3 TSDR to have the highest mean melting temperature (highly methylated) in active SLE patients compared to all the other groups (p?<?0.001). The psoriasis group also had a significantly high mean melting temperature (78.62?±?0.20) when compared with the inactive SLE group (78.49?±?0.29, p?<?0.05) and control group (78.44?±?0.25, p?<?0.01). There was no significant difference in melting temperature between inactive SLE and healthy controls. Disease activity in SLE was directly associated with methylation of the FOXP3 TSDR. On the other hand, patients with chronic microbial infections had significantly lower FOXP3 TSDR mean melting temperature (demethylated) when compared with healthy controls (78.28?±?0.21 vs 78.44?±?0.25, p?<?0.05). Our results suggest that the use of HRM-PCR to detect FOXP3 TSDR methylation status is a reliable and easy method to predict natural regulatory T cell levels in peripheral blood in different disease conditions. Determining FOXP3 TSDR methylation status can be a useful tool in diagnosis, and monitoring the severity of autoimmune diseases and chronic microbial infections. 相似文献
9.
10.
Katharine R. Owen Mollie Donohoe Sian Ellard Andrew T. Hattersley 《Diabetic medicine》2003,20(10):823-827
Background Familial partial lipodystrophy (FPLD) is a monogenic form of diabetes characterised by a dominantly inherited disorder of adipose tissue associated with the loss of subcutaneous fat from the limbs and trunk, with excess fat deposited around the face and neck. The lipodystrophy causes severe insulin resistance, resulting in acanthosis nigricans, diabetes, dyslipidaemia, and increased risk of cardiovascular disease. Preliminary results from animals and man suggest that increasing subcutaneous fat by treatment with thiazolidinediones should improve insulin resistance and the associated features of this syndrome. Case report We report a 24-year-old patient with FPLD caused by a mutation in the LMNA gene (R482W) treated with 12 months of rosiglitazone. Subcutaneous fat increased following rosiglitazone treatment as demonstrated by a 29% generalised increase in skin-fold thickness. Leptin levels increased from 5.8 to 11.2 ng/ml. Compared with treatment on Metformin, there was an increase in insulin sensitivity (HOMA S% 17.2–31.6) but no change in glycaemic control. The lipid profile worsened during the follow-up period. Conclusion This initial case suggests that, for modification of cardiovascular risk factors, there are no clear advantages in treating patients with FPLD with rosiglitazone despite increases in subcutaneous adipose tissue. Larger series will be needed to identify moderate beneficial effects and treatment may be more effective in patients with generalised forms of lipodystrophy. 相似文献